companydata.dkBILLEV PHARMA ApS: Financial statements 2021
CVR: 81814813
BILLEV PHARMA ApS (CVR 81814813) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 25,637,714 and a net result of DKK 5,548,863 compared with DKK 3,786,711 the year before. That is an increase of 19.6% compared with the year before. Equity amounted to DKK 5,868,863. The solvency ratio was 62.7%. The company had 19 employees in the financial year.
- Gross Profit
- 25,637,714 kr.
- Profit/Loss
- 5,548,863 kr.
- Equity
- 5,868,863 kr.
- Total Assets
- 9,366,415 kr.
- Employees
- 19
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 25.6 mio. | 5.5 mio. | 5.9 mio. | 19 |
| 2020 | - | 21.4 mio. | 3.8 mio. | 4.1 mio. | 16 |
| 2019 | - | 17.5 mio. | 2.5 mio. | 2.8 mio. | 14 |
| 2018 | - | 17.1 mio. | 3.7 mio. | 4 mio. | 13 |
| 2017 | - | 14.6 mio. | 2.1 mio. | 2.4 mio. | 13 |
Find more companies like BILLEV PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout BILLEV PHARMA ApS
BILLEV PHARMA ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 1977. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Ulrikke Lynge Jensen and Anja Wencke van Arkens. The company is owned by VAN ARKENS HOLDING ApS and UL JENSEN HOLDING ApS. The company has 15 employees. In 2026, the company reported a gross profit of DKK 38,801,270 and a net result of DKK 10,205,639 compared with DKK 6,143,854 the year before. Equity amounted to DKK 10,525,639.